Corvus Pharmaceuticals, Inc.
DE ˙ DB ˙ US2210151005
9,94 € ↓ -0,31 (-3,02%)
2026-06-05
CENA AKCJI
SecurityDE:C17 / Corvus Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership26,667 shares
Latest Disclosed Value $ 205,336
Group One Trading, L.p. ownership in C17 / Corvus Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 26,667 shares of Corvus Pharmaceuticals, Inc. (DE:C17) valued at $165,069 USD as of December 31, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Corvus Pharmaceuticals, Inc.. The current value of the position is $265,070 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (C17) in the form of stock options. The firm currently holds call options representing 53,600 of underlying shares valued at $412,720 USD and put options representing 33,300 of underlying shares valued at $256,410 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:C17 / Corvus Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 26,667 26,667 205 0.0004
2025-08-14 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -11,895 -100.00 0 -100.00
2025-05-14 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 11,895 -40,873 -77.46 38 -86.88 0.0001
2025-05-14 2024-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 52,768 47,208 849.06 282 872.41 0.0006
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 52,768 47,208 282 0.0007
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 5,560 5,560 29 0.0001
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -4,604 -100.00 0 -100.00
2024-05-10 2024-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 4,604 -32,060 -87.44 8 -87.50 0.0000
2024-02-14 2023-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 36,664 9,565 35.30 65 64.10 0.0002
2023-11-09 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 27,099 27,099 40 0.0001
2023-02-09 2022-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 0 -7,049 -100.00 0 -100.00
2022-11-09 2022-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 7,049 -21,748 -75.52 6 -79.31 0.0000
2022-08-11 2022-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 28,797 19,722 217.32 29 93.33 0.0000
2022-05-12 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 9,075 -20,322 -69.13 15 -78.87 0.0000
2022-02-11 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 29,397 29,397 71 0.0001
2021-11-12 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -7,076 -100.00 0 -100.00
2021-08-10 2021-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 7,076 -2,875 -28.89 19 -38.71 0.0000
2021-05-12 2021-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 9,951 4,551 84.28 31 63.16 0.0000
2021-02-10 2020-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 5,400 5,300 5,300.00 19 0.0000
2020-11-12 2020-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 100 100 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CORVUS PHARMACEUTICALS COM Call 53,600 -16.90 413 -13.26 n/a n/a n/a
2025-11-12 2025-09-30 13F CORVUS PHARMACEUTICALS COM Call 64,500 28.74 475 137.50 n/a n/a n/a
2025-08-14 2025-06-30 13F CORVUS PHARMACEUTICALS COM Call 50,100 -34.08 200 -17.01 n/a n/a n/a
2025-05-14 2025-03-31 13F CORVUS PHARMACEUTICALS COM Call 76,000 -16.67 242 -50.51 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CORVUS PHARMACEUTICALS COM Call 91,200 63.44 488 65.65 n/a n/a n/a
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM Call 91,200 488 n/a n/a n/a
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM Call 55,800 108.21 295 512.50 n/a n/a n/a
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM Call 26,800 294.12 49 300.00 n/a n/a n/a
2024-05-10 2024-03-31 13F CORVUS PHARMACEUTICALS COM Call 6,800 -17.07 12 -14.29 n/a n/a n/a
2024-02-14 2023-12-31 13F CORVUS PHARMACEUTICALS COM Call 8,200 -57.29 14 -50.00 n/a n/a n/a
2023-11-09 2023-09-30 13F CORVUS PHARMACEUTICALS COM Call 19,200 -47.25 28 -66.27 n/a n/a n/a
2023-08-09 2023-06-30 13F CORVUS PHARMACEUTICALS COM Call 36,400 7,180.00 83 n/a n/a n/a
2023-05-12 2023-03-31 13F CORVUS PHARMACEUTICALS COM Call 500 -89.58 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F CORVUS PHARMACEUTICALS COM Call 4,800 -82.29 4 -81.82 n/a n/a n/a
2022-11-09 2022-09-30 13F CORVUS PHARMACEUTICALS COM Call 27,100 -39.51 22 -50.00 n/a n/a n/a
2022-08-11 2022-06-30 13F CORVUS PHARMACEUTICALS COM Call 44,800 895.56 44 528.57 n/a n/a n/a
2022-05-12 2022-03-31 13F CORVUS PHARMACEUTICALS COM Call 4,500 -90.80 7 -94.07 n/a n/a n/a
2022-02-11 2021-12-31 13F CORVUS PHARMACEUTICALS COM Call 48,900 -82.34 118 -91.19 n/a n/a n/a
2021-11-12 2021-09-30 13F CORVUS PHARMACEUTICALS COM Call 276,900 8,553.12 1,340 14,788.89 n/a n/a n/a
2021-08-10 2021-06-30 13F CORVUS PHARMACEUTICALS COM Call 3,200 3.23 9 -10.00 n/a n/a n/a
2021-05-12 2021-03-31 13F CORVUS PHARMACEUTICALS COM Call 3,100 10 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CORVUS PHARMACEUTICALS COM Put 33,300 54.17 256 61.01 n/a n/a n/a
2025-11-12 2025-09-30 13F CORVUS PHARMACEUTICALS COM Put 21,600 46.94 159 174.14 n/a n/a n/a
2025-08-14 2025-06-30 13F CORVUS PHARMACEUTICALS COM Put 14,700 -77.99 59 -72.64 n/a n/a n/a
2025-05-14 2025-03-31 13F CORVUS PHARMACEUTICALS COM Put 66,800 -59.76 212 -76.13 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CORVUS PHARMACEUTICALS COM Put 166,000 5,433.33 888 5,820.00 n/a n/a n/a
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM Put 166,000 888 n/a n/a n/a
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM Put 3,000 36.36 16 275.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM Put 2,200 -43.59 4 -33.33 n/a n/a n/a
2024-05-10 2024-03-31 13F CORVUS PHARMACEUTICALS COM Put 3,900 -9.30 7 -14.29 n/a n/a n/a
2024-02-14 2023-12-31 13F CORVUS PHARMACEUTICALS COM Put 4,300 -24.56 8 -12.50 n/a n/a n/a
2023-11-09 2023-09-30 13F CORVUS PHARMACEUTICALS COM Put 5,700 119.23 8 60.00 n/a n/a n/a
2023-08-09 2023-06-30 13F CORVUS PHARMACEUTICALS COM Put 2,600 6 n/a n/a n/a
2022-11-09 2022-09-30 13F CORVUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F CORVUS PHARMACEUTICALS COM Put 13,300 -26.11 13 -56.67 n/a n/a n/a
2022-05-12 2022-03-31 13F CORVUS PHARMACEUTICALS COM Put 18,000 -16.67 30 -42.31 n/a n/a n/a
2022-02-11 2021-12-31 13F CORVUS PHARMACEUTICALS COM Put 21,600 -26.03 52 -63.12 n/a n/a n/a
2021-11-12 2021-09-30 13F CORVUS PHARMACEUTICALS COM Put 29,200 595.24 141 1,181.82 n/a n/a n/a
2021-08-10 2021-06-30 13F CORVUS PHARMACEUTICALS COM Put 4,200 320.00 11 266.67 n/a n/a n/a
2021-05-12 2021-03-31 13F CORVUS PHARMACEUTICALS COM Put 1,000 -62.96 3 -70.00 n/a n/a n/a
2021-02-10 2020-12-31 13F CORVUS PHARMACEUTICALS COM Put 2,700 3.85 10 0.00 n/a n/a n/a
2020-11-12 2020-09-30 13F CORVUS PHARMACEUTICALS COM Put 2,600 10 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.